Ryoichi Yamagishi

KMD-3213, a uroselective and long-acting alpha(1a)-adrenoceptor antagonist, tested in a novel rat model.

Katsuyoshi Akiyama, Masachiyo Hora, Satoshi Tatemichi et al. · PubMed · 1999 · 89 citations

Benign Prostatic Hypertrophy, Hypertension, Greater Uroselectivity +19

Effect of KMD-3213, an α1a-adrenoceptor-selective antagonist, on the contractions of rabbit prostate and rabbit and rat aorta

Ryoichi Yamagishi, Katsuyoshi Akiyama, S Nakamura et al. · European Journal of Pharmacology · 1996 · 61 citations

Molecular Pharmacology, α1A-adrenoceptor-selective Antagonist, Adrenal Gland +7

KMD-3213, a Uroselective and Long-Acting α1a-Adrenoceptor Antagonist, Tested in a Novel Rat Model

Katsuyoshi Akiyama, Masachiyo Hora, Satoshi Tatemichi et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 60 citations

Purification and biological property of heparin cofactor II: Activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans

Ryoichi Yamagishi, Masahiro NIWA, Shinichi Kondo et al. · Thrombosis Research · 1984 · 57 citations

Biochemistry, Bioanalysis, Glycobiology +9

Effect of KMD‐3213, an <b>α</b>_1A‐adrenoceptor antagonist, on the prostatic urethral pressure and blood pressure in male decerebrate dogs

Katsuyoshi Akiyama, Hiromitsu Noto, Osamu Nishizawa et al. · International Journal of Urology · 2001 · 36 citations